Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies

for
Cancer
Location: Washington DC, Louisville KY, Houston TX,
Sponsor: Advanced Cancer Therapeutics

Sex: All

Age: 18+

Code: NCT02044861

Phase 1, Recruiting

Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)

for
Cannabis Use, Cancer
Location: Saint Louis Park MN
Sponsor: HealthPartners Institute

Sex: All

Age: 18+

Code: NCT07227324

Recruiting

CHIME: Comparing Health Interventions for Maternal Equity

for
Obesity and Overweight, Nutrition, Chronic Disease, Diabetes,
Location: Flushing NY, New York NY
Sponsor: Stanford University

Sex: Female

Age: 18+

Code: NCT06724172

Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05335928

Phase 3, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Scarborough ME, Providence RI, Hartford CT,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

for
Metastatic Solid Tumor, Brain Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05673928

Phase 2, Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

for
Leukemia, Lymphoma, Multiple Myeloma, Blood Cancer,
Location: Calgary
Sponsor: Alberta Health Services, Calgary

Sex: All

Age: 18+

Code: NCT05190653

Recruiting

Patient Derived Preclinical Models

for
Cancer
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05324553

Recruiting

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

for
Colorectal Cancer, Metastatic Cancer
Location: Goshen IN
Sponsor: Goshen Health System

Sex: All

Age: 18+

Code: NCT00408551

Phase 2, Recruiting

An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07772596

Recruiting

The Radiation Oncology Registry and Biosample Repository

for
Neoplasia
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT01577251

Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for
Metastatic Hepatocellular Carcinoma, Solid Tumors,
Location: Boston MA, New York NY, Baltimore MD, Toronto,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase 1, Recruiting

PediRISE Feasibility

for
Pediatric Cancer, Financial Stress, Financial Hardship,
Location: Boston MA, New York NY, San Francisco CA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 17

Code: NCT06283251

Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04219254

Phase 1, Phase 2, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Baltimore MD,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase 1, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Mineola NY, New York NY, Sarasota FL, Portland OR,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase 1, Phase 2, Recruiting

IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

for
Pediatric Cancer, Pediatric Hematology
Location: Edmonton, Calgary
Sponsor: University of Calgary

Sex: All

Age: 5 - 18

Code: NCT04956133

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early Phase 1, Recruiting

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

for
Cancer
Location: West Covina CA
Sponsor: Oeyama-Moto Cancer Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT02340845

Phase 2, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial